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Background: Despite over a decade of research and programming, little evidence is available on effective
strategies to reduce HIV risks among Central American men who have sex with men (MSM). The Pan-American
Social Marketing Organization (PASMO) and partners are implementing a HIV Combination Prevention Program to
provide key populations with an essential package of prevention interventions and services: 1) behavioral, including
interpersonal communications, and online outreach; 2) biomedical services including HIV testing and counseling
and screening for STIs; and 3) complementary support, including legal support and treatment for substance abuse.
Two years into implementation, we evaluated this program’s effectiveness for MSM by testing whether exposure to
any or a combination of program components could reduce HIV risks.
Methods: PASMO surveyed MSM in 10 cities across Guatemala, El Salvador, Nicaragua, Costa Rica, and Panama in
2012 using respondent-driven sampling. We used coarsened exact matching to create statistically equivalent groups
of men exposed and non-exposed to the program, matching on education, measures of social interaction, and
exposure to other HIV prevention programs. We estimated average treatment effects of each component and all
combined to assess HIV testing and condom use outcomes, using multivariable logistic regression. We also linked
survey data to routine service data to assess program coverage.
Results: Exposure to any program component was 32% in the study area (n = 3531). Only 2.8% of men received all
components. Men exposed to both behavioral and biomedical components were more likely to use condoms and
lubricant at last sex (AOR 3.05, 95% CI 1.08, 8.64), and those exposed to behavioral interventions were more likely to
have tested for HIV in the past year (AOR 1.76, 95% CI 1.01, 3.10).
Conclusions: PASMO’s strategies to reach MSM with HIV prevention programming are still achieving low levels of
population coverage, and few men are receiving the complete essential package. However, those reached are able
to practice HIV prevention. Combination prevention is a promising approach in Central America, requiring
expansion in coverage and intensity.
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Despite several decades of work [1,2], there is still in-
sufficient evidence of how to effectively reach men who
have sex with men (MSM) in low and middle-income
countries with effective prevention programming, par-
ticularly in settings where stigma and homophobia are
prevalent and MSM are difficult to reach. An estimated
112,000 people in Central America were newly infected
with HIV in 2010. MSM in Central America are one of
the most affected key populations in the region, with
HIV prevalence ranging from 7.5% to 11.1% [3,4]. Invest-
ments have been made in Central America to target key
populations including MSM, but evidence is extremely
limited on the effectiveness of these investments [5-7].
We aim here to assess the effectiveness of one combin-
ation prevention program for reducing HIV risks among
MSM across 5 countries in Central America.
That MSM in Central America experience elevated HIV
risks is well documented. High levels of unprotected anal
intercourse have been reported in Nicaragua and El
Salvador. Condom use is frequent, but the picture of con-
sistent condom use is not clear, and in 2013, 60.2% of
MSM reported sometimes or never using condoms with
their partners [8,9]. Use of HIV testing and counseling
(HTC) is variable across the region, despite high levels of
awareness of services [8-10]. HIV testing in the past year
ranged from 54% in San Salvador, El Salvador in 2008 to
72% in Chinandega, Nicaragua in 2009 [11,12].
HIV risk behaviors among MSM occur in a context of
stigma and violence. Central America experiences high
levels of generalized violence along with homophobia
targeted against MSM and transgender women [13-15].
Stigmatizing social environments increase the vulner-
ability of MSM to a range of physical and mental health
risks [1,8,16]. Violence against men, especially homosex-
ual men, including forced sex, is common, along with
MSM being refused services from health care providers
[8,13,16,17].
Given structural factors, such as homophobia and vio-
lence, it is difficult to reach targeted populations at im-
pactful levels of coverage and challenging to maintain
these contacts. In Central America and elsewhere, the
HIV community is increasingly mobilized around com-
bination prevention strategies, recognizing that it is not
possible to get traction on the epidemic through isolated
efforts that do not address contexts of risk [18,19]. A
combination prevention approach includes biomedical
interventions that block the biological mechanisms
through which HIV transmission occurs or reduce the
chance of acquisition of infection, such as provision of
condoms, STI treatment, pre-exposure prophylaxis, and
post-exposure prophylaxis, as well as evidence-based be-
havioral interventions that use communications chan-
nels to promote behaviors that reduce HIV risk – whichon their own can be effective but are difficult to sustain -
as well as generate demand for biomedical interventions
[20,21]. Critically, combination prevention also includes
structural interventions to address the social drivers of the
epidemic to create environments more supportive for vul-
nerable populations [18,20-22]. Structural interventions
cover a wide scope of approaches, for example cash trans-
fers, community dialogue, sensitivity training for law en-
forcement and health providers, and political advocacy, to
address the multiple levels of social interactions that influ-
ence HIV risk and transmission [22]. These interventions
operate at the population level and aim to address an indi-
vidual’s risk through indirect, upstream mechanisms that
shape norms, behaviors and health outcomes in the popu-
lation as a whole [23]. Best practice recommends that the
specific combination of interventions to be implemented
from within the three components should be designed
based on local epidemiology and social conditions [24].
While combination prevention is increasingly the con-
sensus framework for HIV prevention, there is as yet little
evidence on the effectiveness of different combination pre-
vention strategies [25]. The need to evaluate the combin-
ation prevention approach is clear, given the complexity of
evaluating multi-level programming, but few dedicated
studies have been conducted [26].
Program description
With support from USAID (United States Agency for Inter-
national Development), the Pan-American Social Marketing
Organization (PASMO) and Population Services Inter-
national (PSI)/Mexico began implementing a Combination
Prevention Program for HIV with community-based
partners in 2011 across Belize, Guatemala, El Salvador,
Nicaragua, Panama, Costa Rica, and Mexico. The program
is designed to increase access to HIV prevention interven-
tions in order to reduce risk behaviors among key popula-
tions and reduce social hostility that contributes to stigma
and discrimination.
PASMO has defined an essential package of interven-
tions for MSM following a combination prevention ap-
proach [27]. To receive a complete package, an individual
client should have a) participated in at least three behavior
change communication interventions conducted by out-
reach teams or through online outreach, b) received a re-
ferral for biomedical services such as HTC or screening
for sexually transmitted infections (STI), and c) received a
referral to a set of complementary services.
The behavioral component includes integrated behav-
ior change communications activities conducted by out-
reach workers. Based on the transtheoretical model and
Population Services International’s PERForM framework,
these activities were designed to generate demand for
the program’s products and services, while also encour-
aging individuals reached to assess their health risks and
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conducted in person one-on-one, one-to-group or online
through cyber-educators. Using Prochaska’s Stages of
Change framework, outreach workers identify the stage
a targeted individual is in to be able to practice a specific
behavior being promoted, such as condom use or use of
HTC, and tailor delivery of activities according to that
stage through discussion and reflection [29]. Outreach
workers also ensure that condoms and lubricants are
available for sample or purchase near to where activities
are being implemented [31].
The biomedical component is core to the Combination
Prevention program’s design. Services provided include
HTC, STI screening and treatment, and for people living
with HIV, referrals for care and treatment, including
antiretroviral therapy. A variety of service providers par-
ticipate in the program, including private laboratories,
private and NGO clinics, and some public sector facil-
ities. HTC is provided through fixed and mobile services,
according to where the program is operating [31].
The addition of complementary services was designed
to support program clients to locate resources that help
them negotiate potential stigma and discrimination [31].
These specifically include referrals to designated service
providers for support groups, drug and alcohol treat-
ment, legal support, and violence prevention services. In
addition, the program operates beyond the interpersonal
level to address stigma and discrimination and change
social norms through sensitization and training of health
care providers to improve perceived quality of care,
media training, and mobilization of civil society leaders
to foster public dialogue on homophobia and discrimin-
ation against people living with HIV.
Integrated HIV prevention teams conduct behavioral
interventions and referrals to biomedical and comple-
mentary services in identified high-risk zones in pro-
gram cities. For MSM, these zones are areas with large
concentrations of nightclubs, bars, parks and areas
where community organizations have identified that
MSM are likely to meet each other. Teams include out-
reach workers, PASMO sales staff responsible for ensur-
ing availability and access to condoms, community
leaders, and service providers. When clients are con-
tacted by an outreach worker, they receive an in-person
behavioral intervention plus a packet of vouchers for
other behavioral interventions, condoms, biomedical ser-
vices, and complementary services. The program tracks
client contacts and use of referral vouchers via unique
identifier codes assigned to each client contacted [32].
While conducting direct service delivery and coordinat-
ing with other program partners, PASMO and partners
have also implemented a set of advocacy strategies as
part of the structural component of the program. Advo-
cacy is designed to encourage public discussion of HIVtransmission and encourage reduction in social hostility
towards key populations including MSM [33].
We aimed in this paper to provide early results on PAS-
MO’s combination prevention program, as targeted to
MSM in Central America. Two years into implementing
the program, our objectives were to 1) assess population-
level coverage of specific and combined intervention com-
ponents and 2) determine whether program exposure to
any or a combination of components was associated with
HIV risk reduction behaviors, specifically condom and
water-based lubricant use, HIV testing and counseling,
and appropriate treatment of STIs.
Methods
Data sources and measures
We used behavioral survey data and data extracted from
PASMO’s program monitoring system for this analysis.
Regional survey of MSM
From September-November 2012, PASMO recruited
MSM from 10 cities in six Central American countries
into a survey using respondent-driven sampling (n =
4231). The survey was conducted in areas where the
Combination Prevention program operates: Belize City
in Belize, San Jose in Costa Rica, San Salvador and Santa
Ana in El Salvador, Guatemala City and Quetzaltenango
in Guatemala, Managua and Chinandega in Nicaragua,
and Panama City and Colón in Panama. These cities
were selected because they had on-going program opera-
tions and national level evidence indicated high pro-
jected HIV prevalence in each city [3,34]. Men were
eligible to participate in the study if they were aged 18–
40, had had anal sex with another man in the past
3 months, were resident in the study city, and knew the
name or alias of the person who had recruited that re-
spondent to participate. Respondent-driven sampling is a
chain referral sampling technique developed to improve
the population representativeness of surveys of hard-to-
reach populations [35,36]. We recruited 1–3 seeds in
each city. We selected seeds based on socio-economic
status, self-identification of sexual orientation, and work-
ing in commercial sex. Each seed was asked to recruit
three peers within his social network to participate in
the study, and subsequent study participants were asked
to recruit an additional three peers.
Data was collected through in-person interviews
administered by a male enumerator in a location that
ensured the respondent’s privacy. The survey instrument
included questions on socio-demographic characteris-
tics, sexual behaviors, STI symptoms, use of STI treat-
ment and HTC services, mass media and program
exposure, knowledge and attitudes regarding HIV pre-
vention, and experience with violence. The PSI Research
Ethics Board provided ethical approval of this survey
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Guatemala and Nicaragua. The Panama National HIV/
AIDS Program and the University of Medical Sciences in
Costa Rica approved the study as well. Individuals were
asked to provide informed consent before participating
in the interview. No identifying information was col-
lected from respondents.
For this analysis, we did not use data from Belize be-
cause program operations were not completely compar-
able. We also excluded transgender women (n = 400
self-identified cases) from this analysis because trans-
gender women are increasingly considered to be a separ-
ate population programmatically and epidemiologically
[37]. Our final analytical sample was 3531 men.
Routine data
We also used data extracted from PASMO’s routine pro-
gram monitoring system. PASMO’s system for applied
monitoring (SAM) tracks BCC activities and service
utilization across all program implementers in six coun-
tries. A key feature of the SAM is the use of unique
identifier codes (UICs) to track individual clients across
program contacts. Unique identifier codes are based on
personal information that does not vary over time and
that clients can easily recall. Monitoring data are col-
lected on BCC activities by type of activity and target
population reached, messages and behaviors, referrals
initiated and completed, plus client use of HTC, and STI
treatment, and any referrals to other services, such as
CD4 count and viral load testing for people living with
HIV. Data on program contacts and service utilization
are aggregated by country and reported to partners on a
monthly basis. For this analysis, we extracted data from
October 1, 2011-September 30, 2012. No identifying in-
formation on program clients was collected, and analysis
of this data was determined to not constitute research
with human subjects. From extraction of routine data,




Five outcome measures were used for this analysis, all
taken from behavioral survey data: 1) condom use at last
sex, 2) condom use with water-based lubricant at last
sex, 3) consistent condom use in the past 30 days, 4) re-
ceipt of an HIV test in the past 12 months, and 5) seek-
ing medical care for a suspected STI symptom in the
past 12 months. Consistent condom use was defined as
using a condom from start to finish for all sex acts with
any partner type for the past 30 days. We measured con-
sistent condom use by partner type for commercial, cas-
ual and regular partners. Commercial partners were
partners from whom the respondent received money orto whom the respondent gave money for sex. Casual
partners were defined as partners with whom the re-
spondent had sex with no emotional attachment and no
financial transaction. Regular partners were defined as
partners with whom the respondent had engaged in sex
for more than 3 months and felt connected to, either by
love or friendship.Program exposure
We created several measures of program exposure from be-
havioral survey data. These measures were designed to cap-
ture specific components of the combination prevention
approach in order to capture program operations and assess
potentially additive effects of the different components. Ex-
posure to behavioral interventions was defined as having
been contacted by an outreach worker representing the pro-
ject. Exposure to biomedical interventions was defined as
having received a voucher for HIV testing and counseling,
to capture the referral process. Exposure to complementary
interventions was defined as receiving a voucher for other
services. We defined any exposure to the program as receipt
of any one of these components. We also created a measure
of having received all three components, defined as the
combination package.
After extracting individual records from the program
monitoring system, we created measures of receipt of
behavioral interventions (y/n, and number of interven-
tions), receipt of biomedical services (y/n and number of
services), and receipt of complementary interventions
(y/n and number of services) for this analysis.Other measures
We considered a range of other factors from the survey
data for this analysis. We looked at socio-demographic
factors of age, education (primary education or less,
some secondary education, any higher education), and
an index of socio-economic status. The index of socio-
economic status was constructed following methods of
the Mexican Market Research Association and grouped
individuals into categories of high, medium and low
socio-economic status [38]. We also considered how
men described their sexual identity (gay, bisexual,
heterosexual).
We considered a series of factors assessing men’s so-
cial interactions with gay, transgender and other MSM
communities. These included: friends’ knowing the re-
spondent’s sexual orientation, having participated in a
gay/transgender event in the past 12 months, and going
to a gay bar/disco in the past 30 days. We also consid-
ered exposure to other HIV/AIDS programming target-
ing MSM, measured as whether the respondent received
a condom for free in the past 12 months. All factors
were treated as dichotomous variables.
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Weighting
For descriptive sample characteristics, we present un-
weighted data. We conducted weighted analyses to assess
program effects using multiple logistic regression. Because
of our sampling and analysis strategy, we calculated
weights using pooled data. Several types of weights were
calculated and adjusted for in regression models. First, we
calculated RDS weights using RDSAT software, which ac-
counts for network size and recruitment patterns for each
city [39]. Second, we estimated city weights to account for
differential proportions of the sample and estimated popu-
lation size of each city. Because reliable estimates of the
population size of men who have sex with men in all 9 cit-
ies were not available, we weighted by the city population
of men 15–39 years [40]. Population size estimates were
retrieved from national statistics bureaus in each country
[41-45]. Age- and sex-specific population size estimates
were not available for Guatemala, and we therefore ap-
plied the national proportion of men in Guatemala to the
age distribution for each city. A third set of weights was
used as well, derived from the matching procedure de-
scribed below. These weights were multiplied together
and applied in regression models. Data analysis was con-
ducted in Stata 13 and SPSS 22.
Statistical matching
We next used a statistical matching technique, coarsened
exact matching (CEM), to improve the quality of our esti-
mates of program effects [46-48]. Coarsened exact matching
was used to create statistically equivalent groups of survey
respondents exposed and not exposed to any program com-
ponent. This quasi-experimental approach allowed us to
designate a counterfactual (no exposure to any Combination
Prevention program components) when an experimental
design was not feasible, since program implementation was
ongoing at scale across several countries and was not de-
signed or implemented with intervention and control
groups [47,49]. Coarsened exact matching is a monotonic
imbalance matching method designed to reduce imbalance
between treatment and control groups in observational data
[49,50]. CEM assigns each case into one of a specified set of
strata in which members are exactly matched on a set of
coarsened, or categorized, variables [46]. Matched cases are
then assigned a weight specific to that stratum and repre-
sentative of the proportion of all cases present in the
stratum [51,52].
We matched survey respondents on factors likely to
influence exposure to PASMO’s combination prevention
program, given the strong likelihood of selection bias in
a setting where MSM are highly stigmatized [53]. We
matched on education (categorized as primary education
or less, any secondary education, any higher education),
sexual orientation (heterosexual, homosexual, bisexual),whether the respondent’s friends knew he had sex with
other men, whether the respondent had participated in a
gay/transgender event in the past 12 months, whether
the respondent had been to a gay bar or disco in the past
30 days, and whether the respondent had received free
condoms in the past 12 months. We assessed relation-
ships between potential matching variables and any pro-
gram exposure using Spearman correlation coefficients.
We matched variables that had a statistically significant
correlation with program exposure at p < 0.05. An exact
match made on the coarsened variables yielded an L1
measure of 4.814e-16, indicating minimal imbalance be-
tween respondents exposed and not exposed [46].
Modeling strategy
We calculated un-weighted descriptive statistics for key
measures using country data and pooled data. Descriptive
statistics in the pooled dataset were calculated for the full
and the matched samples. We next compared distributions
of program exposure in the survey data to program expos-
ure from monitoring data by country. We then used
weighted multivariable logistic regression to estimate odds
ratios of average treatment effects for each measure of
program participation, applying all three types of weights
(RDSAT weights, city weights, CEM weights). We first esti-
mated unadjusted odds ratios for each outcome of interest.
We next adjusted for age and socio-economic status –
factors not included in the matching procedure. We also
investigated the effects of receiving two combination pre-
vention channels (behavioral + biomedical and behavioral +
complementary), with and without controls. The same
modeling strategy was used in the full sample and with the
matched sub-sample to estimate how estimates of treatment
effects changed following matching.
Analysis of combined survey and MIS data
Finally, we created a new sub-sample of cases where we
could link unique identifiers between routine data and sur-
vey data. Because of the limited sample size for these linked
cases, we did not apply any sampling weights, and we did
not match because all cases were exposed. We conducted
chi-square tests of association between type of program
exposure and the outcomes of interest by country.
Results
More than 80% of respondents across all countries were
under 30 (Table 1). Half of the surveyed men were edu-
cated at the secondary level and 40% had some university,
except for Costa Rica where a quarter of the sample had
only primary education. The majority of men were of mid-
dle or lower socio-economic status. Half of respondents
identified as homosexual or gay, 40.5% as bisexual, and
8.4% as heterosexual. Trends in sexual identity varied by
country; Panama had a relatively greater proportion of

















18–24 50.7 67.5 57.7 74.4 48.6 58.9 63.9
25–29 24.7 16.7 18.0 16.0 25.8 20.6 16.7
30–34 14.7 9.8 11.3 7.3 14.6 11.8 11.2
≥34 9.9 6.0 12.9 2.3 11.0 8.8 8.2
Education
Primary or less 25.1 6.5 16.1 9.9 2.1 12.0 8.1
Secondary 57.7 22.9 23.5 72.0 68.6 49.2 44.6
Tertiary 17.1 70.6 60.4 18.1 29.2 38.8 47.3
Socio-economic status
Low 54.4 57.7 39.7 70.1 60.3 56 54.7
Middle 40.7 39 50 28.7 37.3 39.5 40.2
High 4.9 3.4 10.3 1.2 2.3 4.5 5.1
Sexual identity
Heterosexual 13.3 15.7 5.1 4.7 3.9 8.4 4.1
Bisexual 51.5 38.1 51.9 39.3 22.5 40.5 36.9
Gay/homosexual 35.2 46.2 43.1 56.0 73.7 51.1 59.1
Social interaction
Out with friends 63.0 70.4 66.3 72.8 78.3 70.2 78.5
Participated in gay/LGBT event in past 12 months 29.3 32.5 30.4 43.4 30.8 32.9 43.8
Visited gay bar/disco in past 30 days 64.5 46.2 62.4 62.0 78.8 62.5 72.4
Received free condoms in past 12 months 47.6 63.7 78.1 67.9 40.1 58.8 71.4
Ever participated as an HIV/AIDS educator 7.5 8.7 9.5 15.2 11.4 10.4 11.7
Behavioral outcomes
Condom use at last sex 84.1 84.1 90.4 84.9 82.9 85.0 84.0
Condom and lubricant use at last sex 45.3 33.9 59.5 37.0 61.3 47.5 48.7
Consistent condom use, all partners 79.3 80.4 82.1 86.4 84.4 82.2 80.4



















Table 1 Characteristics of men who have sex with men in Central America, 2012 (Continued)
Consistent condom use, commercial partners 87.8 (n = 237) 96.5 (n = 113) 92.7 (n = 205) 95.6 (n = 91) 92.4 (n = 118) 92.0 (n = 764) 92.8 (n = 91)
Consistent condom use, casual partners 88.7 (n = 327) 90.4 (n = 230) 90.2 (n = 418) 91.3 (n = 208) 90.3 (n = 422) 90.1 (n = 1605) 91.1 (n = 188)
Received an HIV test, past 12 months 39.3 57.6 52.4 55.4 56.3 52.1 61.9
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Rica and El Salvador had larger proportions of men
reporting they were heterosexual. The majority (70%) of
respondents indicated that they had disclosed their sexual
identity to their friends, 33% had participated in a gay/
transgender event in past 12 months, and 63% had visited
a gay bar or disco in the past 30 days.
Of the outcomes of interest, 85% of men reported
having used a condom at last sex, and 48% used a con-
dom with water-based lubricant at last sex. Regarding
consistent condom use, 82% reported consistent condom
use in the past 30 days with all partners. Consistent
condom use was substantially higher when respondents
reported having casual partners (90%) and commercial
partners (92%). Just over half of respondents reported
having had an HIV test in the last 12 months (52%),
and of those with STI symptoms, 76% sought medical
treatment.
Almost a third (32.2%) of respondents reported expos-
ure to any component of the Combination Prevention
program (Table 2). Across the five countries, exposure
to the behavioral component reached 17.4% and was
highest in Guatemala (27.9% overall and 74.2% of those
with any exposure) and lowest in Costa Rica and
Panama. Coverage of the biomedical component reached
16.4% of men regionally, with El Salvador and Panama
achieving the greatest levels of biomedical exposure. Ex-
posure to complementary interventions was reported by
11.2% of respondents regionally; the reach of the com-
plementary component was minimal in Costa Rica but
reached 65% of those with any exposure in El Salvador.
Only 2.8% of respondents received all three components
of the program, with El Salvador (6.1%) and Guatemala
(5.5%) achieving the greatest levels of population-based
coverage of combination prevention exposure.
We also report trends in program exposure from pro-
gram monitoring data. Based on how the data were
collected, exposure to behavioral interventions was con-
siderably greater than to any other component across all
countries, ranging from 84 to 100% of reported contacts.
Only El Salvador and Guatemala reported anything
other than minimal levels of biomedical contacts (16.5%
and 22.7%, respectively), while El Salvador and
Nicaragua had the greatest reported contacts with com-
plementary services (both at 3.4%).
Table 3 reports findings from models estimating pro-
gram effects for the outcomes of interest. We do not show
modeling results for consistent condom use with casual
partners or for STI treatment seeking, where there were
no findings. Men exposed to any programmatic compo-
nent were more likely to use condoms consistently with
regular partners (OR 1.69; 95% CI 1.09, 2.62) and to have
been tested for HIV (AOR 2.98; 95% CI 1.82, 4.87). Men
exposed to the behavioral component were more likely touse a condom with water-based lubricant the last time
they had sex (OR 1.84; 95% CI 1.08, 3.14), to use condoms
consistently with regular partners (AOR 1.88; 95% CI 1.09,
3.25), and to have tested for HIV in the past 12 months
(OR 1.76; 95% CI 1.001, 3.10). Exposure to the comple-
mentary component was also associated with HIV testing
(OR 1.97; 95% CI 1.0, 4.05). The odds of condom and
water-based lubricant use were greater when men received
both the behavioral and biomedical component (OR 3.05;
96% CI 1.08, 8.64). Exposure to both behavioral and com-
plementary components was associated with consistent
condom use with commercial partners in the full sample
prior to matching (OR 2.47; 95% CI 1.00, 6.09), but after
matching, these results were not statistically significant.
Overall, we found no evidence that receipt of all three
program components was associated with any of the out-
comes of interest, although this measure of exposure was
rare.
We were able to link a total of 520 unique individuals
between monitoring and survey data (Table 4). These
cases were comparable to the full sample on socio-
demographic factors, except that cases in Guatemala
were somewhat younger on average than all men (results
not shown). Consistent condom use with regular part-
ners was higher for linked cases, except in Nicaragua.
Use of condoms with water-based lubricant and HIV
testing were both greater among linked cases in Costa
Rica than in the full sample. Most MSM had been ex-
posed to 1–2 behavioral activities, although in Costa
Rica a quarter were exposed to more than five. Com-
paratively fewer of the linked cases had received any bio-
medical services. The country with the highest level of
biomedical service use was Guatemala (22% of cases).
Use of complementary services was rare. Overall, El
Salvador and Nicaragua achieved the greatest levels of
combination prevention exposure, but coverage was still
low at 7.3% and 6.8%, respectively. No relationship be-
tween program exposure and behavioral outcomes was
statistically significant when tested with chi-square tests
of association.
Discussion
In light of the need for a larger evidence base on the ef-
fectiveness of combination prevention, particularly from
Latin America, we have aimed in this study to systemat-
ically evaluate a program strategy that seeks to link mul-
tiple program components for a priority population in
Central America. We aimed to assess population-level
coverage of a combination prevention program targeted
to men who have sex with men and to determine
whether program exposure was associated with HIV risk
reduction in this population. We present preliminary
evidence here that suggests this strategy is associated
with condom use with water-based lubricant at last sex,
Table 2 Exposure to combination prevention intervention channels among men who have sex with men






























N 736 1065 630 2881 750 2907 618 3886 797 4312 3531 2922
Any 18.9 41.4 40.2 37.8 25.8 32.2 35.5
Behavioral 9.5 58.8 100 23.3 56.5 91.0 27.9 74.2 84.0 19.4 56.5 97.9 9.7 50.0 98.2 17.4 18.9
Biomedical 10.8 47.1 0.0 22.7 45.7 16.5 17.5 38.7 22.7 20.3 47.8 8.2 12.1 50.0 2.8 16.4 17.2
Structural 1.8 11.8 1.2 26 65.2 3.4 16.6 45.2 0.6 5.9 17.4 3.4 4.1 18.2 1.3 11.2 12.4
Combination 0.3 0.0 6.1 15.2 5.5 16.1 1.6 4.3 0.6 4.5 2.8 3.0



















Table 3 Associations with combination prevention program exposure for behavioral outcomes among MSM across five
Central American countries
Full sample (n = 3531)* Matched sample (n = 2922)**
Condom use at last sex with any partner
OR (95% CI) Adj OR (95% CI)*** OR (95% CI) Adj OR (95% CI)***
Any 1.49 (0.81, 2.74) 1.50 (0.81, 2.79) 1.44 (0.74, 2.82) 1.44 (0.73, 2.84)
Behavioral 1.56 (0.72, 3.35) 1.55 (0.72, 3.35) 1.57 (0.67, 3.66) 1.56 (0.66, 3.69)
Biomedical 1.64 (0.65, 4.13) 1.67 (0.65, 4.26) 1.73 (0.63, 4.71) 1.73 (0.62,4.81)
Complementary 1.24 (0.50, 3.05) 1.26 (0.50, 3.13) 1.11 (0.44, 2.84) 1.10 (0.42, 2.84)
Behavioral + Biomedical 2.32 (0.467, 11.46) 2.16 (0.43, 10.78) 2.48 (0.42, 14.64) 2.39 (0.40, 14.32)
Behavioral + Complementary 1.38 (0.37, 5.20) 1.33 (0.35, 5.05) 1.29 (0.33, 5.09) 1.21 (0.30, 4.88)
Combination 2.35 (0.24, 22.80) 2.26 (0.23–22.09) 2.50 (0.20, 30.82) 2.48 (0.20, 31.26)
Condom and lubricant use at last sex with any partner
OR (95% CI) Adj OR (95% CI) OR (95% CI) Adj OR (95% CI)
Any 1.35 (0.90, 2.02) 1.32 (0.87, 1.99) 1.40 (0.90, 2.17) 1.31 (0.84, 2.05)
Behavioral 1.73 (1.06, 2.83) 1.66 (1.01, 2.74) 1.84 (1.08, 3.14) 1.70 (0.98, 2.95)
Biomedical 1.54 (0.88, 2.71) 1.53 (0.86, 2.71) 1.71 (0.94, 3.12) 1.57 (0.85, 2.90)
Complementary 0.86 (0.47, 1.58) 0.86 (0.47, 1.59) 0.86 (0.46, 1.61) 0.83 (0.44, 1.58)
Behavioral + Biomedical 3.14 (1.22 ,8.13) 2.88 (1.10, 7.51) 3.51 (1.26, 9.80) 3.05 (1.08, 8.64)
Behavioral + Complementary 1.50 (0.64, 3.54) 1.44 (0.61, 3.42) 1.56 (0.64, 3.80) 1.43 (0.58, 3.53)
Combination 3.54 (0.91, 13.75) 3.33 (0.85, 13.04) 4.12 (0.94, 18.15) 3.76 (0.84, 16.88)
Consistent condom use in the last 30 days with all partner types
OR (95% CI) Adj OR (95% CI) OR (95% CI) Adj OR (95% CI)
Any 1.17 (0.66, 2.06) 1.21 (0.68, 2.16) 1.38 (0.75, 2.53) 1.37 (0.70, 2.50)
Behavioral 1.01 (0.52, 1.97) 1.05 (0.53–2.07) 1.13(0.55, 2.30) 1.17 (0.56, 2.44)
Biomedical 1.47 (0.63, 3.45) 1.45 (0.61, 3.46) 1.89 (0.75, 4.77) 1.82 (0.71, 4.65)
Complementary 0.82 (0.38, 1.80) 0.82 (0.37,1.81) 0.93 (0.41, 2.09) 0.90 (0.39, 2.04)
Behavioral + Biomedical 1.12 (0.34, 3.67) 1.09 (0.33, 3.60) 1.28 (0.37, 4.45) 1.23 (0.35, 4.37)
Behavioral + Complementary 0.71 (0.25, 2.02) 0.69 (0.24, 1.99) 0.84 (0.28, 2.48) 1.09 (0.30, 3.98)
Combination 0.72 (0.17, 3.10) 0.70 (0.16, 3.06) 0.90 (0.19, 4.22) 0.85(0.18, 4.17)
Consistent condom use in the last 30 days with regular partners
OR (95% CI) Adj OR (95% CI) OR (95% CI) Adj OR (95% CI)
Any 1.72 (1.15, 2.57) 1.71 (1.13, 2.57) 1.69 (1.09, 2.62) 1.51 (0.88, 2.57)
Behavioral 1.83 (1.12, 3.00) 1.78 (1.08, 2.93) 1.88 (1.10, 3.21) 1.88 (1.09, 3.25)
Biomedical 1.18 (0.68, 2.05) 1.17 (0.67, 2.05) 1.19 (0.66, 2.14) 1.19 (0.65, 2.17)
Complementary 1.64 (0.90, 3.00) 1.63 (.089, 3.01) 1.50 (0.79, 2.82) 1.53 (0.80, 2.90)
Behavioral + Biomedical 1.66 (0.71,, 3.88) 1.56 (0.66, 3.67) 1.74 (0.71, 4.28) 1.63 (0.67, 4.19)
Behavioral + Complementary 1.81 (0.76, 4.30) 1.72 (0.72, 4.10) 1.69 (0.69, 4.16) 1.67 (0.67, 4.14)
Combination 1.41 (0.43, 4.54) 1.33 (0.41,4.32) 1.34 (0.39, 4.57) 1.31 (0.38, 4.56)
Consistent condom use in the last 30 days with commercial partners
OR (95% CI) Adj OR (95% CI) OR (95% CI) Adj OR (95% CI)
Any 1.47 (0.91, 2.37) 1.58 (0.97, 2.59) 1.39 (0.83, 2.33) 1.51 (0.88, 2.57)
Behavioral 1.44 (0.82, 2.53) 1.58 (0.89,2.83) 1.36 (0.74, 2.50) 1.5 (0.79 ,2.78)
Biomedical 0.99 (0.51, 1.93) 1.03 (0.52, 2.03) 0.86 (0.428, 1.74) 0.9 (0.45, 1.90)
Complementary 1.87 (0.97, 3.62) 1.95 (1.00, 3.82) 1.69 (0.84, 3.38) 1.8 (0.87, 3.61)
Behavioral + Biomedical 0.88 (0.30, 2.59) 0.94 (0.32, 2.80) 0.78 (0.25, 2.44) 0.8 (0.26, 2.68)
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Table 3 Associations with combination prevention program exposure for behavioral outcomes among MSM across five
Central American countries (Continued)
Behavioral + Complementary 2.34 (0.96, 5.70) 2.47 (1.00, 6.09) 2.11 (0.84, 5.32) 2.2 (0.85, 5.69)
Combination 1.44 (0.38, 5.41) 1.52 (0.40, 5.82) 1.28 (0.312, 5.18) 1.4 (0.32, 5.66)
Had an HIV test and received results in the last 12 months
OR (95% CI) Adj OR (95% CI) OR (95% CI) Adj OR (95% CI)
Any 3.98 (2.54, 6.23) 4.06 (2.57, 6.42) 3.04 (1.88, 4.91) 2.98 (1.82, 4.87)
Behavioral 2.49 (1.49, 4.17) 2.48 (1.47, 4.18) 1.86 (1.07, 3.22) 1.76 (1.01, 3.10)
Biomedical
Complementary 2.54 (1.28, 5.08) 2.55 (1.27, 5.12) 1.97 (1.0, 4.05) 1.95 (0.94, 4.03)
Behavioral + Biomedical
Behavioral + Complementary 3.52 (1.23, 10.13) 3.45 (1.19, 9.97) 2.77 (0.93, 8.30) 2.63 (0.87, 7.93)
Combination 39.58 (0.80, 1978.03) 37.78 (0.75, 1894.03) 43.22 (0.37, 5070.70) 40.03 (0.34, 4716.04)
Estimates in bold are statistically significant at p < 0.05.
*Results weighted for network size, recruitment chain, and city population size.
**Results weighted for network size, recruitment chain, city population size, and matching stratum.
***Models adjusted for age and socio-economic status.
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testing.
Two years into implementation, PASMO’s Combin-
ation Prevention program has achieved fairly modest








Condom use at last sex 89.7
Condom and lubricant use at last sex 65.5
Received an HIV test, past 12 months 48.3
Combination Prevention program exposure
Mean number of behavioral exposures 3.35
No behavioral exposure, % 0
1–2 interactions, % 55.2
3–5 interactions, % 20.7
>5 interactions, % 24.1
Mean number of biomedical exposures 0.0
No biomedical exposure, % 0.0
1 biomedical service, % 0.0
> 1 biomedical service, % 0
Mean number of complementary exposures 0.04
Exposure to behavioral + biomedical, % 0.0
Exposure to behavioral + complementary, % 3.4
Exposure to biomedical + complementary, % 0.0
Combination prevention exposure, % 0.0population that is notably difficult to reach [54,55]. Con-
dom use was relatively high in this population, but con-
dom use with water-based lubricant less so. These levels
of condom use are consistent with other reports from









77.9 84.9 89.2 88.8
59.3 60.1 55.7 60.7
34.1 58.7 37.5 41.4
80.3 89.6 89.8 84.1
30.3 59.4 43.2 64.5
69.9 72.5 68.2 72.1
2.41 1.8 2.43 1.44
3.3 11.6 5.7 6.4
67.5 70.3 71.6 80.7
19.5 12.3 14.8 12.1
9.8 5.8 8 0.7
0.23 0.41 0.23 0.16
82.9 70.3 78.4 84.3
13.8 22.5 20.5 15.0
3.3 7.2 1.1 0.7
0.08 0.01 0.08 0.07
13.8 18.1 15.9 9.3
7.3 0.7 8 4.3
7.3 0.7 6.8 7.1
7.3 0.7 6.8 4.3
Firestone et al. BMC Public Health 2014, 14:1244 Page 12 of 15
http://www.biomedcentral.com/1471-2458/14/1244tended to be slightly higher, particularly with casual part-
ners, than recent IBBS surveys in in El Salvador,
Guatemala and Nicaragua [11,12,57]. Over half of the
population had received an HIV test in the past year,
except in Costa Rica where receipt of testing was less
common. These results were similar to the 2008 IBBS in
El Salvador, but the 2009 Nicaragua IBBS reported
higher levels of HIV testing in the past year compared to
our study [11,12]. STI treatment practices were highly
variable across countries, but overall trends indicate that
appropriate treatment-seeking was common.
Program coverage varied across countries, indicating
that the program was at different stages of penetration
into the target population. Exposure to the behavioral
component of the program was most common at a
population level, followed closely by exposure to referral
for biomedical services Panama and Costa Rica both had
relatively lower levels of exposure to the behavioral com-
ponent, reflecting that these countries were relatively
newer sites for program implementation than Guatemala
or El Salvador. Variation in biomedical program expos-
ure was likely due in part to differing periods of program
operation.
The picture of program exposure based on records of
contacts from monitoring data is somewhat different.
Several countries showed high service utilization, but
trends differed from survey data. This suggests issues
with under-reporting in the monitoring system, likely
due to problems with voucher redemption, and is com-
pounded by likely under-reporting of program exposure
through recall bias in survey data. Despite the potential
for discrepancies, exposure to the complementary com-
ponent was consistently low across data sources and
countries. The notable exception was Guatemala, where
complementary exposure was 45% of exposure amongst
survey respondents with any exposure. This suggests that
the program was more successful in implementing the
voucher mechanism and service linkages in that country.
Modalities of program implementation also account
for some of the differences in exposure trends. Specific-
ally in Costa Rica, the program operates solely through
referrals to the public sector Social Security Institute,
following government policy on maintaining HTC
services as a public sector service. Rapid HIV tests are
not yet available in Costa Rican clinics, which may have
influenced outcomes there. Based on coverage levels in
other countries, including in Panama where the program
also only recently began implementation, loosening
policy guidelines on service providers and types of HTC
services that can be provided in Costa Rica may be
merited to increase the use of HTC.
Despite modest levels of coverage and inconsistencies
across data sources, there is evidence that participation
in the Combination Prevention program was associatedwith HIV risk reduction. The behavioral component was
associated with consistent condom use with regular part-
ners and with using condoms and water-based lubricants
at last sex. Both of these behaviors are focuses of messa-
ging during behavioral interactions. Print materials are
distributed that demonstrate the importance of using
condoms with water-based lubricant, and counselors are
trained to talk about lubricant use in pre- and post-
counseling. Effect estimates more than doubled for men
who had received both the behavioral component and
referral to biomedical services, suggesting that a greater
dose of exposure was particularly effective at promoting
water-based lubricant use with condoms.
Based on previously collected data showing compara-
tively lower levels of condom use with regular partners,
compared to with casual or commercial partners,
PASMO specifically focused messaging within BCC ac-
tivities on condom use with regular partners during the
period evaluated by this study [58-61]. The finding that
exposure to the behavioral component was associated
with condom use with regular partners suggests that
interpersonal communications and a structured ap-
proach to BCC can be effective for influencing specific
behaviors. Condom use across all partner types is now
relatively high, suggesting that future messaging should
focus on continued maintenance of these behaviors,
along with greater adoption of the use of water-based
lubricants.
There was also evidence that program exposure was asso-
ciated with HIV testing, particularly the exposure to the
behavioral component. The effectiveness of referral to com-
plementary services was attenuated in the matched sample,
and having received both program components was associ-
ated with an even higher likelihood of HIV testing, but these
results were not statistically significant, likely due to the
small numbers of men who reported both components.
These results suggest that BCC strategies are effectively able
to promote use of HIV testing and counseling services. The
program’s emphasis on improving quality of care within
testing service providers, adapting service hours to be con-
venient for the population being served, and helping service
providers to treat client respectfully likely contributed to
these results, along with making referrals to these service
providers. Subsequent evaluations of this program should
continue to investigate whether service linkages and making
services MSM-friendly are able to achieve increases in de-
mand for and use of HTC services. This study was not de-
signed to assess links between HIV testing and care and
treatment services, but other data from the Combination
Prevention program suggest that the program has contrib-
uted to improved access to care and treatment for people
living with HIV [62].
After linking cases from monitoring with survey data, we
found no evidence that program exposure was associated
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rarity of exposure, a result of challenges in locating men ex-
posed to the program during survey data collection and
perhaps inconsistencies in reporting of unique identifiers.
Future survey research to evaluate this program may be able
to address these challenges of recall during data collection.
The Combination Prevention program results are aligned
with recent evidence from the HIV prevention literature
and contribute unique results on condom use with water-
based lubricants, especially in regards to the doubling of ef-
fect size for men who were exposed to both the behavioral
and biomedical components in the program. Several evalua-
tions from large-scale HIV prevention efforts focused on
MSM show an increase in consistent condom use with
regular male partners, some with all male partners [63-65].
Community-based peer interventions show evidence of in-
creased condom use at last sex with a male partner and in-
creased perception of behavioral control in taking up HIV
testing and counseling [66]. The Combination Prevention
program, as well other programs for MSM in low and
middle-income countries found to be effective, require add-
itional investments to increase depth and breadth of pro-
gram coverage.Limitations
This analysis has several limitations. In the survey data, re-
call of outcomes may have been biased. However, levels of
condom use and of HIV testing were comparable to other
reports from the region [56]. Program exposure recall may
have been biased as well. Comparison with program moni-
toring data suggests that program exposure recall from sur-
vey data may have been under-reported, thus attenuating
estimates of coverage and effectiveness. The survey did not
collect data on HIV status, either through self-report or bio-
markers, nor were we able to go beyond experience with
HIV testing to look at whether this program links HIV test-
ing and counseling to the HIV treatment cascade, priority
areas for understanding the effectiveness of HIV prevention
strategies and linking prevention to a continuum of care
[67]. We also suspect under-reporting of program contacts
in monitoring data, due to the need for program beneficiar-
ies to redeem vouchers before registering in the system.
Under-reporting may have attenuated estimates.
Another potential study limitation was in the coarsening
of variables before matching. The matching procedure we
used faces a trade-off in increasing the number of matched
pairs at the expense of less exact matching [49,51]. However,
categorical variables were less likely to be affected by this
potential source of bias. This analysis is also at risk for
omitted variable bias, as we were not able to account for the
effects of unobservable factors.
The measurement approach taken here primarily assesses
program exposure and outcomes based on individual-levelmeasurement. It has been argued that combination preven-
tion programs require a multi-level exposure measurement
approach or evaluation platform approach to assess the ef-
fects of structural factors [25,26]. We were not able to
measure changes at a structural level that may have been
related to the program. However, measurement of the com-
plementary component may stand in for some of these
gaps, in that these services, including legal support and
counseling on drug and alcohol use, influence other factors
that affect risk. Further research and later rounds of the
evaluation may investigate how to capture the advocacy
and social mobilization components better.
Conclusions
We have early evidence that a combination prevention strat-
egy is associated with HIV risk reduction among MSM in
Central America. Additional strategies are needed to expand
program coverage into a population that is difficult to reach
due to stigma and discrimination. Service linkages appear to
strengthen program impacts, but measurement may be
hampered by under-reporting. Future evaluations should
take a multi-level approach to account for complex program
operations and the multiple levels (societal, social network,
interpersonal) at which a combination prevention strategy
operates.
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